期刊文献+

TGF-β1基因修饰的脾细胞对大鼠肝脏移植免疫耐受的实验研究 被引量:1

Transforming growth factor β1 gene-modified donor spleen cell transfuntion induced liver transplantation immune tolerance in rats
下载PDF
导出
摘要 目的研究TGF-β1修饰的供者脾细胞特异性输注对大鼠移植肝脏耐受的诱导及效果。方法每组选10只雄性SD大鼠为供体,10只雄性Wistar大鼠为受体建立大鼠原位肝脏移植模型,于移植前7天分别经尾静脉输注TGF-β1基因修饰的脾细胞(5×106/mL)1mL、脾细胞(5×106/mL)1 mL、空质粒1 mL、生理盐水1 mL。观察TGF-β1修饰的脾细胞输注组、脾细胞输注组、空质粒输注组、肝移植组存活天数和病理改变及凋亡情况。结果 TGF-β1修饰的脾细胞特异性输注可明显延长移植肝脏存活时间(36.4±4.16)d,与脾细胞输注组(20.0±4.00)d、空质粒输注(7.8±0.84)d、肝移植组(8.4±1.4)d比较,差异有统计学意义(P<0.05);而且可明显减轻移植肝脏的病理损伤。结论输注TGF-β1基因修饰的供体脾细胞可诱导大鼠移植肝脏的耐受产生。 Objective To study whether TGF-β1 gene-modifide donor spleen cell transfuntion could induce immune tolerance of liver transplatation.Methods In each group,selected 10 male Sprague-Dawely rats as donor and 10 male Wistar rats were established as a receptor for orthotopic liver transplantation.7 days before transplantation,TGF-β1 gene-modified spleen cells(5×106/mL) 1 mL,spleen cells(5×106/mL) 1 mL,empty vector 1 mL,normal saline 1 mL were infused via the tail vein,respectively.Survival time,the pathological changes and apoptosis were observed in each group.Results TGF-β1-modified spleen cells transfusion could significantly prolong the survival time of orthotopic liver transplantation(36.4±4.16)d,compared with spleen cell infusion group(20.0±4.00) d,empty plasmids infusion(7.8±0.84)d,liver transplantation group(8.4±1.4)d,there was significantly different among four groups(P0.05);and could significantly reduce the pathological damage of the transplanted liver.Conclusion The infusion of TGF-β1 gene modified donor spleen cells can induce the production of rat liver graft immune tolerance.
出处 《胃肠病学和肝病学杂志》 CAS 2012年第4期331-335,共5页 Chinese Journal of Gastroenterology and Hepatology
基金 黑龙江省科技厅攻关项目(GC09C409-1)
关键词 转化生长因子β1 肝脏移植 移植耐受 TGF-β1 Liver transplantation Transplantation tolerance
  • 相关文献

参考文献15

  • 1夏穗生.临床移植医学[M]杭州:浙江科学技术出版社,1999150-191.
  • 2郑树森.肝脏移植[M]北京:人民卫生出版社,20011-2.
  • 3Juan FS,Miguel Q,Carmelo B. TGF-β/TGF-β receptor system and its role in physiological and pathological conditions[J].Clinical Science,2011,(06):233-251.
  • 4Kamada N,Calne RY. Orthotopic liver transplantation in therat.Technique using cuff for portal vein anastomosis and biliarydrainage[J].Transplantation,1979,(01):47-50.doi:10.1097/00007890-197907000-00011.
  • 5马毅,何晓顺,陈规划.大鼠原位肝移植模型的手术技巧及并发症的预防[J].中华显微外科杂志,2003,26(1):45-47. 被引量:61
  • 6Polyak K,Kato JY,Solomon MJ. p27Kipl,a cyclin-Cdk inhibitor,Links transforming growth factor-beta and contact inhibition to cell cycle arrest[J].Genes and Development,1994,(01):9-22.
  • 7Eliopoulos N,Stagg J,Lejeune L. Allogeneic marrow stromal cells are Immune rejected by MHC class I-and class Ⅱ-mismatched recipient mice[J].Blood,2005,(13):4057-4065.
  • 8Lu LN,Lee WC,Takayama T. Genet ic engineering of dendritic cells to express immunosuppressive molecules (viral IL-10,TGFβ1 and CTLA4Ig)[J].J Leu Biol,1999,(02):293-307.
  • 9刘宁,段体德,郑南.TGF-β_1基因修饰树突状细胞对免疫排斥反应影响的研究[J].四川大学学报(医学版),2006,37(5):721-725. 被引量:2
  • 10Qin L,Chvain KD,Ding Y. Gene transfer for transplantation.Prolongation of allograft survival with transforming growth factor-betal[J].Transplantation,1994,(04):508-518.

二级参考文献30

  • 1孟庆刚,洪光祥,钱贵宾,岳琦,张凤蕴,王立峰,孙立国.胸腺内注射异基因抗原诱导鼠神经移植免疫耐受的实验研究[J].中华手外科杂志,2006,22(1):47-49. 被引量:11
  • 2尹方明 李铁林 胡耀民 等.神经生长因子高亲合力受体在损伤坐骨神经的表达[J].中华实验外科杂志,2002,19:255-255.
  • 3[1]Iton N, Tsujimoto M, Willis PW, et al. Effect of bcl-2 on antigenmediated cell death. J Immunol, 1993,146(6):621~7.
  • 4[2]Koukoulis GK,Shen J,Karademir S, et al. Cholangiocytic apoptosis in chronic ductopenic rejection. Hum Pathol, 2001,32(8): 823~7.
  • 5[3]Krams SM, Martinez OM. Apoptosis as mechanism of tissue injury in liver allograft rejection. Semin Liver Dis, 1998,18(2):153~67.
  • 6[4]Korsmeyer SJ. Bcl-2 gene family and the regulation of programmed cell death. Cancer Res, 1999,59:1693~700.
  • 7[5]Paul C, Benediktsson H. Chronic transplantation rejection: Magnitude of the problem and pathogenetic mechanisms. Transplantation Reviem, 1993,7(2):96~113.
  • 8[6]Nawaz S, Fennel RA. Apoptosis of bile duct epithelial cells in hepatic allofraft rejection. Histopathology, 1994,25:13~4.
  • 9[7]Van Gelder T, Aggle HMM Balk A, Jonkman F, et al. A randomized trial comparing safety and efficacy of OKT3 and a monoclonal anti-interleukin-2 receptor antibody (BT563) in the prevention of acute rejection after heart transplantation. Transplantation,1996,62(1):51~5.
  • 10[8]Borghi-Scoazec G, Scoazec JY, Durand F, et al. Apoptosis after ischemiareperfusion in human liver allografts. Liver Transpl Surg,1997,4:407~15.

共引文献67

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部